STOCK TITAN
  1. Home
  2. Sec-filings
  3. INDB
  4. [8-K] INDEPENDENT BANK CORP Reports Material Event

Independent Bank (NASDAQ: INDB) CEO shares lymphoma diagnosis, continues role

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Independent Bank Corp. disclosed that President and Chief Executive Officer Jeffrey Tengel has been diagnosed with lymphoma. He told employees the cancer type is highly treatable, he has begun chemotherapy, and he expects a full recovery.

Tengel plans to continue working while adjusting his schedule, with support from the Executive Leadership Team and Board of Directors. He may limit attendance at large in‑person events during treatment but emphasized that the bank’s strategy, mission, and leadership focus remain unchanged.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Understanding 8-K Material Events →
8-K3/4/2026INDEPENDENT BANK CORP.Massachusetts1-9047781878-61000000776901false00007769012026-03-042026-03-040000776901dei:MailingAddressMember2026-03-042026-03-04

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15 (d) of
The Securities and Exchange Act of 1934

DATE OF REPORT:
March 4, 2026
(Date of Earliest Event Reported)

Massachusetts
(State or Other Jurisdiction of Incorporation)
1-904704-2870273
(Commission File Number)(I.R.S. Employer identification No.)
INDEPENDENT BANK CORP.
Office Address:2036 Washington Street,Hanover,Massachusetts02339
Mailing Address:288 Union Street,Rockland,Massachusetts02370
(Address of principal executive offices, including zip code)

NOT APPLICABLE
(Former Address of Principal Executive Offices)

(781)-878-6100
(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each ClassTrading SymbolName of each exchange on which registered
Common Stock, $0.01 par value per shareINDBNASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17CFR 230.405)) or Rule 12b-2 of the Exchange Act (17CFR 240.12b-2).
Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☐



ITEM 8.01OTHER EVENTS
On Wednesday, March 4, 2026, Jeffrey Tengel, President and Chief Executive Officer of Rockland Trust Company and Independent Bank Corp. (INDB), issued a letter to employees and colleagues regarding a recently diagnosed medical condition. A copy of his letter is attached as Exhibit 99.1.


ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS

d. The following exhibits are included with this Report:
Exhibit Index
Exhibit #Exhibit Description
99.1
Letter of Jeffrey Tengel, President and Chief Executive Officer of Rockland Trust Company and Independent Bank Corp.
104Cover page interactive data file (embedded within the Inline XBRL document).



















SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned and hereunto duly authorized.
INDEPENDENT BANK CORP.
Date:March 4, 2026By:/s/Patricia M. Natale
PATRICIA M. NATALE
General Counsel






















Exhibit 99.1

Team,

Today, I want to share some personal news with you. I’ve always believed that strength comes from honesty and from facing reality together. This is one of those moments.

I have recently been diagnosed with Lymphoma. It’s not easy news to deliver, but I’m receiving excellent care, and the type of cancer I have is highly treatable. With my wife by my side, I have begun chemotherapy, and I expect to make a full recovery.

I plan to continue working and adjust my schedule as needed. I’ve communicated with the Executive Leadership Team and our Board of Directors, and I’m very grateful for their full support. We have an exceptional leadership team, and I have complete confidence in our collective ability to keep moving forward and achieve all of the strategic goals we have established.

One change you may notice is that I need to be cautious around large groups of people while undergoing treatment; therefore, I may not be able to attend as many large gatherings as I’d like, including some of our colleague celebrations. If you notice I am not at an event I would typically attend, please know it’s because I’m adhering to the treatment plan that I’ve been advised to follow. I genuinely value and enjoy connecting in person, so thank you for your understanding and patience during this time.

Our strategy remains intact. Our mission remains unchanged. And my belief in the collective team has never been stronger.

Thank you for the work you do, and for the culture of support, integrity, and resilience we’ve built together. It matters deeply, especially now. After all, we are the Bank Where Each Relationship Matters.

Jeff Tengel
President and Chief Executive Officer




Source: View Original Filing on SEC EDGAR

FAQ

What health update did Independent Bank Corp. (INDB) disclose about its CEO?

Independent Bank Corp. reported that CEO Jeffrey Tengel has been diagnosed with lymphoma. In a letter to employees, he described the cancer as highly treatable, noted he has started chemotherapy, and stated that he expects to make a full recovery while continuing in his role.

Will Independent Bank Corp. (INDB) CEO Jeffrey Tengel continue working during treatment?

Jeffrey Tengel plans to continue working while undergoing chemotherapy. He said he will adjust his schedule as needed, has informed the Executive Leadership Team and Board, and expressed confidence in the leadership team’s ability to pursue the company’s strategic goals during his treatment.

How might Jeffrey Tengel’s lymphoma treatment affect his public appearances for INDB?

Tengel stated he must be cautious around large groups during treatment, so he may attend fewer large gatherings and colleague celebrations. He emphasized that any absence from events reflects adherence to his medical treatment plan, and he thanked employees for their understanding and support.

Did Independent Bank Corp. (INDB) indicate any change to its strategy after the CEO’s diagnosis?

The company’s CEO said its strategy and mission remain intact despite his diagnosis. He reaffirmed his strong belief in the organization’s culture and leadership team, emphasizing that the bank will continue pursuing its established strategic goals while he undergoes treatment for lymphoma.

What support does Jeffrey Tengel have from Independent Bank Corp. (INDB) leadership?

Tengel said he has communicated his diagnosis and treatment plan to the Executive Leadership Team and Board of Directors. He reported receiving their full support and highlighted confidence in the leadership team’s ability to move forward and execute the bank’s strategic plans during his recovery.

Filing Exhibits & Attachments

5 documents

Press Releases

Other Documents